The results of this study showed novel therapies targeting fibrin clot lysis time may improve prognosis in patients with acute coronary syndrome. (Source: File Photo) The results of this study showed novel therapies targeting fibrin clot lysis time may improve prognosis in patients with acute coronary syndrome. The results showed novel therapies targeting fibrin clot lysis time may improve prognosis in patients with acute coronary syndrome. For the study, published in European Heart Journal, researchers analysed blood plasma samples from more than 4,300 patients with acute coronary syndrome as they were discharged from hospital. They measured the maximum density of a clot and the time it took for the clot to break down — known as clot lysis time.

Source: Indian Express February 08, 2018 15:22 UTC